Well, if you have the time and resources to learn what the basics are, they are more then worth the effort you put into mastering the craft. The same rules apply to self taught music video directors too – if you have the time or know-how to learn how to make good video videos, you too are a valuable asset to this industry and can earn a lot more.
If you want to be successful with music video production, you need to understand the basics of how to shoot videos and how to make an attractive, well directed video. And yes, that means everything from cinematography to composition to set design to editing and post production.
I highly suggest that you consider learning as much as you can about filmmaking and how to apply it to your music video production.
So, what advice have you got for self taught music video directors looking to be in the industry? Let us know in the comments below.
[Source: Geeet.com | Image Credits: iStock]
The world’s biggest pharmaceutical company says that it’s been warned by the EU’s competition commissioner about a “serious and persistent misbehaviour” at one of its overseas pharmacies.
Sir Martin Sorrell, the UK’s competition commissioner, accused GlaxoSmithKline (GSK) of “conduct designed to exclude competition in the UK and to prevent effective competition in the EU”.
The accusations are the latest embarrassment for the UK’s world-leading drug company after other similar claims about its marketing have been denied.
The European parliament’s competition committee reported in December that the company had breached EU and British market rules on price competition and paid almost £3.5bn in fines to the European Commission.
The case revolves around some of the drugs sold at GlaxoSmithKline’s Pharmapathie and Hospira pharmacies in Spain – including Tamiflu and Lipitor – and are a key part of a wider case related to the price of drugs.
UK drugs regulator told to act
In its report into the UK’s medicines regulation, the parliament’s committee warned that the UK authorities were lacking their powers and that the regulatory regime in place to make sure medicines did not reach consumers over the counter was under-resourced.
The drugs used by the pharmacies – which represent almost 500,000 patients – were listed by GlaxoSmithKline with the EU as “available for import within the EU”, which meant they could be imported under rules which require a special
kline creative, anime art lessons online free, free online art lessons homeschool connections catholic online, free online art lessons for teens, free online art classes for middle school